Jasper Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -14.2% | +301.0% | -48.4% | +96.2% | -15.8% | -55.2% | |
| – | -23.8% | +324.6% | -52.5% | +113.1% | -14.8% | -54.3% | |
| – | -27.0% | +327.0% | -54.8% | +127.2% | -17.6% | -59.9% | |
| – | -27.0% | +327.0% | -54.8% | +127.2% | -17.6% | -59.9% | |
| – | – | +16.3% | +66.0% | -78.4% | – | – | |
| – | – | -674.0% | – | – | – | – | |
| – | – | +138.2% | -26.2% | – | – | – | |
| – | +857.4% | -58.7% | -48.7% | +33.0% | +10.8% | +73.5% | |
| – | +101.3% | +99.9% | -11.9% | +75.1% | +23.1% | -13.4% | |
| – | – | – | +71.3% | +12.4% | +12.0% | +13.4% | |
| – | +127.4% | +176.6% | -54.9% | +134.7% | -2.9% | +54.5% | |
| – | – | – | – | – | – | – | |
| – | -266.5% | – | -48.2% | +118.0% | -21.4% | -93.3% | |
| – | – | – | – | – | – | – | |
| – | -1.7% | +558.7% | +220.2% | +186.1% | +39.7% | +31.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.